Dr Mayimuna Nalubega

Mayimuna completed a PhD at The University of Queensland and the Queensland Institute of Medical Research (QIMR Berghofer) in 2025, under the supervision of Dr Michelle Boyle, with doctoral research focused on CD4+ T cell responses in human malaria.

Mayimuna has more than 10 years of experience in malaria clinical trials and immunology studies, working in collaboration with the Infectious Diseases Research Collaboration (IDRC) Uganda, University of California, San Francisco (UCSF), and Stanford University. Currently, her research in the Boyle lab investigates the impact of malaria on germinal centre responses.

Utilising advanced immunological techniques and human lymphoid tissues, Mayimuna aims to identify strategies that could inform the design of more effective malaria vaccines. 

• 2025: PhD, The University of Queensland, Australia
• 2018: Master of Science in Medical Microbiology, The University of Manchester, United Kingdom
• 2016: Bachelor of Medical Laboratory Science, Mbarara University of Science and Technology, Uganda

• 2024–present: Research officer, Burnet Institute
• 2018–2021: Laboratory scientist, Infectious Diseases Research Collaboration (IDRC), Uganda
• 2010–2017: Laboratory technician, Infectious Diseases Research Collaboration (IDRC), Uganda

• 2022: QIMR Berghofer Student Travel Award
• 2022: Best student poster, Lorne Infection and Immunity Conference
• 2022: 10x/Millennium Science Fellowship Program award
• 2021: Research Training Program (RTP) scholarship, The University of Queensland
• 2017: Equity and Merit scholarship, The University of Manchester, United Kingdom
• 2016: The Best Bachelor of Medical Laboratory Sciences Graduate Convocation Award of Mbarara University of Science and Technology, Uganda